Bodnar-Broniarczyk, M.; Warzyszyńska, K.; Czerwińska, K.; Marszałek, D.; Dziewa, N.; Kosieradzki, M.; Pawiński, T.
Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients. Pharmaceutics 2022, 14, 632.
https://doi.org/10.3390/pharmaceutics14030632
AMA Style
Bodnar-Broniarczyk M, Warzyszyńska K, Czerwińska K, Marszałek D, Dziewa N, Kosieradzki M, Pawiński T.
Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients. Pharmaceutics. 2022; 14(3):632.
https://doi.org/10.3390/pharmaceutics14030632
Chicago/Turabian Style
Bodnar-Broniarczyk, Magdalena, Karola Warzyszyńska, Katarzyna Czerwińska, Dorota Marszałek, Natalia Dziewa, Maciej Kosieradzki, and Tomasz Pawiński.
2022. "Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients" Pharmaceutics 14, no. 3: 632.
https://doi.org/10.3390/pharmaceutics14030632
APA Style
Bodnar-Broniarczyk, M., Warzyszyńska, K., Czerwińska, K., Marszałek, D., Dziewa, N., Kosieradzki, M., & Pawiński, T.
(2022). Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients. Pharmaceutics, 14(3), 632.
https://doi.org/10.3390/pharmaceutics14030632